{
    "clinical_study": {
        "@rank": "124364", 
        "arm_group": [
            {
                "arm_group_label": "Esophagogastroduodenoscopy (EGD) with Dilation", 
                "arm_group_type": "Active Comparator", 
                "description": "Standard of Care: EGD with dilation alone. If participants are assigned to Arm A and are not showing any clinical improvements as determined by their physician after the first three endoscopic dilation sessions, then they will be crossed over into Arm B."
            }, 
            {
                "arm_group_label": "EGD with Dilation, plus Triamcinolone", 
                "arm_group_type": "Experimental", 
                "description": "Standard of Care: EGD with dilation, plus Triamcinolone injection"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out if adding triamcinolone (steroid) injection at the\n      participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of\n      their esophagus and decrease the need for repeat dilations."
        }, 
        "brief_title": "Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Dysphagia", 
        "condition_browse": {
            "mesh_term": [
                "Deglutition Disorders", 
                "Dilatation, Pathologic", 
                "Esophageal Stenosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a randomized two-arms cross-over trial. In this study there are two groups, the\n      control group and the triamcinolone treatment group. The cross-over design will apply only\n      in the control group when patients are not responding to EGD dilations alone (defined as no\n      sustained improvement in baseline dysphagia) and they will be allowed to cross-over to the\n      triamcinolone group and undergo 3 successive EGDs with triamcinolone injection."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who present for EGD with dilation for dysphagia symptoms thought secondary\n             to either radiation-induced stricture or anastomotic stricture based on history\n\n        Exclusion Criteria:\n\n          -  Inability to consent for the procedure\n\n          -  Known coagulopathy [International Normalized Ratio (INR) >1.5, Platelets <75 K]\n\n          -  Endoscopic finding of a stricture that is not caused by either radiation or\n             anastomotic narrowing\n\n          -  Nasopharyngeal strictures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01873573", 
            "org_study_id": "MCC-17316"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Esophagogastroduodenoscopy (EGD) with Dilation", 
                    "EGD with Dilation, plus Triamcinolone"
                ], 
                "description": "Dilation will be performed by either dilation balloons or over the wire polyvinyl dilators based upon the physician's discretion. Fluoroscopy may be used to aid in endoscopic dilation at the physician's discretion.", 
                "intervention_name": "Dilation", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "EGD with Dilation, plus Triamcinolone", 
                "description": "After endoscopic dilation is performed, a total of 40-80mg(physician preference) of triamcinolone (40mg/ml) will be injected throughout the stricture under direct visualization.", 
                "intervention_name": "Triamcinolone Injection", 
                "intervention_type": "Drug", 
                "other_name": [
                    "steroid", 
                    "corticosteroid", 
                    "Kenalog 10"
                ]
            }, 
            {
                "arm_group_label": [
                    "Esophagogastroduodenoscopy (EGD) with Dilation", 
                    "EGD with Dilation, plus Triamcinolone"
                ], 
                "description": "EGD is a test to examine the lining of the esophagus (the tube that connects your throat to your stomach), stomach, and first part of the small intestine. It is done with a small camera (flexible endoscope) that is inserted down the throat.", 
                "intervention_name": "Esophagogastroduodenoscopy (EGD)", 
                "intervention_type": "Device", 
                "other_name": "flexible endoscope"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Triamcinolone hexacetonide", 
                "Triamcinolone", 
                "Triamcinolone Acetonide", 
                "Triamcinolone diacetate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "radiation-induced stricture", 
            "anastomotic stricture", 
            "esophagogastroduodenoscopy (EGD)", 
            "dilation", 
            "steroid injection", 
            "triamcinolone", 
            "difficulty swallowing"
        ], 
        "lastchanged_date": "May 5, 2014", 
        "link": {
            "description": "Moffitt Cancer Center Clinical Trials website", 
            "url": "http://www.moffitt.org/research--clinical-trials/clinical-trials"
        }, 
        "location": [
            {
                "contact": {
                    "email": "raman@mednet.ucla.edu", 
                    "last_name": "Muthuasamy Venkataraman, M.D.", 
                    "phone": "310-267-3636"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA Medical Center"
                }, 
                "investigator": {
                    "last_name": "Muthuasamy Venkataraman, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "shahj@sutterhealth.org", 
                    "last_name": "Janak Shah, M.D.", 
                    "phone": "415-600-1151"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }, 
                    "name": "California Pacific Medical Center"
                }, 
                "investigator": {
                    "last_name": "Janak Shah, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Sachin.wani@ucdenver.edu", 
                    "last_name": "Sachin Wani", 
                    "phone": "720-848-2786"
                }, 
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80045"
                    }, 
                    "name": "University of Colorado Anschutz Medical Campus"
                }, 
                "investigator": {
                    "last_name": "Sachin Wani, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "david.daniels@moffitt.org", 
                    "last_name": "David Daniels", 
                    "phone": "813-745-3960"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center and Research Institute"
                }, 
                "investigator": [
                    {
                        "last_name": "Jason Klapman, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Cynthia Harris, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Shivakumar Vignesh, M.D.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "koman1973@gmail.com", 
                    "last_name": "Sri Komanduri, M.D.", 
                    "phone": "312-695-0484"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Sri Komanduri, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Controlled Trial of Endoscopic Dilation With or Without Triamcinolone Injection in Patients With Non-malignant Radiation or Anastomotic Esophageal Strictures", 
        "overall_contact": {
            "email": "jason.klapman@moffitt.org", 
            "last_name": "Jason Klapman, M.D.", 
            "phone": "813-745-4035"
        }, 
        "overall_official": {
            "affiliation": "H. Lee Moffitt Cancer Center and Research Institute", 
            "last_name": "Jason Klapman, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The main outcome measured will be number of visits to receive Esophageal Dilation during the 12-month follow-up period. Successful dilation of the stricture for the procedure will be defined as creation of a mucosal tear confirmed by endoscopic visualization after the last dilation is performed.", 
            "measure": "Number of Visits to Receive Esophageal Dilation During the 12 Month Follow-up Period", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01873573"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Dysphagia Scoring System: 0 = able to eat normal diet / no dysphagia; 1 = able to swallow some solid foods; 2 = able to swallow only semi solid foods; 3 = able to swallow liquids only; 4 = unable to swallow anything / total dysphagia.", 
            "measure": "Final Dysphagia Score", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "H. Lee Moffitt Cancer Center and Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "H. Lee Moffitt Cancer Center and Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}